The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-arm, exploratory study of disitamab vedotin (DV) combined with camrelizumab and platinum-based chemotherapy as first-line treatment in patients with HER2 expressing locally advanced or metastatic esophageal squamous cell carcinoma (ESCC).
 
Meihong Wu
No Relationships to Disclose
 
Yingyi Zhang
No Relationships to Disclose
 
Dan Feng
No Relationships to Disclose
 
Bin Wang
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Tianran Chen
No Relationships to Disclose
 
Anjing Zhao
No Relationships to Disclose
 
Meng Xu
No Relationships to Disclose
 
Linli Zhang
No Relationships to Disclose
 
Xianbao Zhan
No Relationships to Disclose